Search results
Results from the WOW.Com Content Network
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
This Dividend Champion is another fresh idea for investors that pays a hefty 5.70% dividend. NNN REIT Inc. (NYSE: NNN) invests primarily in high-quality retail properties subject generally to long ...
Best of all, AT&T's shares can be had for only about 10 times its forecasted free cash flow for 2025 (and 9 times its projections for 2027). Additionally, its stock currently yields a hefty 4.9% ...
This page was last edited on 23 January 2025, at 14:33 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Beverage giant PepsiCo (NASDAQ:PEP) is the first Dividend King to buy for 2025. Its stock has been largely flat for the past few years, trading in a band between $165 per share and $175 per share.
2 Dividend Stocks and 1 ETF That Beat the S&P 500 in 2024, and Are Still Worth Buying in 2025 Daniel Foelber, Scott Levine, and Lee Samaha, The Motley Fool January 14, 2025 at 4:15 AM
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see...
The stock’s rock-solid dividend and its growth potential from a number of positive wins suggest GSK stock will still climb higher. GlaxoSmithKline Is More Than Just a 5% Dividend Income Play ...